Recent Finacing
Recent Raise
GlyTR Therapeutics develops an immunotherapy platform targeting tumor-associated carbohydrate antigens by binding cancer-specific glycans to recruit T cells to kill tumors, based in Irvine, California.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at GlyTR Therapeutics.
